These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 15364230

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma.
    Friedman DS, Wilson MR, Liebmann JM, Fechtner RD, Weinreb RN.
    Am J Ophthalmol; 2004 Sep; 138(3 Suppl):S19-31. PubMed ID: 15364049
    [Abstract] [Full Text] [Related]

  • 3. Glaucoma risk factor assessment and prevention: lessons from coronary heart disease.
    Girkin CA, Kannel WB, Friedman DS, Weinreb RN.
    Am J Ophthalmol; 2004 Sep; 138(3 Suppl):S11-8. PubMed ID: 15364048
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The probability of glaucoma from ocular hypertension determined by ophthalmologists in comparison to a risk calculator.
    Mansberger SL, Cioffi GA.
    J Glaucoma; 2006 Oct; 15(5):426-31. PubMed ID: 16988606
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The impact of physician subspecialty training, risk calculation, and patient age on treatment recommendations in ocular hypertension.
    Boland MV, Quigley HA, Lehmann HP.
    Am J Ophthalmol; 2011 Oct; 152(4):638-645.e1. PubMed ID: 21742305
    [Abstract] [Full Text] [Related]

  • 9. Lifetime visual disability in open-angle glaucoma and ocular hypertension.
    Forsman E, Kivelä T, Vesti E.
    J Glaucoma; 2007 May; 16(3):313-9. PubMed ID: 17438426
    [Abstract] [Full Text] [Related]

  • 10. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials.
    Maier PC, Funk J, Schwarzer G, Antes G, Falck-Ytter YT.
    BMJ; 2005 Jul 16; 331(7509):134. PubMed ID: 15994659
    [Abstract] [Full Text] [Related]

  • 11. Unpredictability of glaucoma progression.
    Susanna R.
    Curr Med Res Opin; 2009 Sep 16; 25(9):2167-77. PubMed ID: 19601708
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk factors for glaucoma onset and progression.
    Coleman AL, Miglior S.
    Surv Ophthalmol; 2008 Nov 16; 53 Suppl1():S3-10. PubMed ID: 19038621
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results?
    Parrish RK.
    Curr Opin Ophthalmol; 2006 Apr 16; 17(2):138-41. PubMed ID: 16552248
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology.
    Dueker DK, Singh K, Lin SC, Fechtner RD, Minckler DS, Samples JR, Schuman JS.
    Ophthalmology; 2007 Sep 16; 114(9):1779-87. PubMed ID: 17822980
    [Abstract] [Full Text] [Related]

  • 20. Risk assessment in glaucoma and ocular hypertension.
    Medeiros FA, Weinreb RN.
    Int Ophthalmol Clin; 2008 Sep 16; 48(4):1-12. PubMed ID: 18936633
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.